Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AMR Centre

AMR Centre
2016 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$2.92M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of new antibiotics and diagnostics created to respond to the global threat of antimicrobial resistance. The company's operations include the development of needed antimicrobial drugs and diagnostics through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept, enabling companies and research institutions to support the development of their products from lead optimization, so that the threat of antimicrobial resistance can be significantly reduced.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 19B70, Mereside
  • Alderley Park, Cheshire
  • Alderley Edge SK10 4TG
  • England, United Kingdom

+44 0161 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AMR Centre’s full profile, request a free trial.

AMR Centre Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 22-Mar-2019 $2.92M 00.000 00.000 Completed Startup
3. Early Stage VC 12-Jul-2018 00000 00000 00.000 Completed Startup
2. Early Stage VC 19-Jul-2017 Completed Startup
1. Accelerator/Incubator 13-Apr-2017 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AMR Centre Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 2,210,000 $0.013038 $1.3 $1.3 1x $1.3 50.22%
To view this company’s complete Cap Table, request access »

AMR Centre Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bruntwood Corporation Minority 000 0000 000000 0
Greater Manchester Investment Fund Venture Capital Minority 000 0000 000000 0
LifeArc Venture Capital Minority 000 0000 000000 0
Catapult Ventures Venture Capital Minority 000 0000 000000 0

AMR Centre Executive Team (3)

Name Title Board
Seat
Contact
Info
Dawn Watson Chief Financial Officer
Derek Lindsay Chief Operating Officer
Peter Jackson Executive Director and Board Member

AMR Centre Board Members (5)

Name Representing Role Since Contact
Info
Chris Doherty Ph.D AMR Centre Board Member 000 0000
Hakim Yadi Ph.D Self Board Member 000 0000
Jon Moulton AMR Centre Chairman 000 0000
Peter Jackson AMR Centre Executive Director and Board Member 000 0000
Tony Flinn Ph.D Catapult Ventures Board Member 000 0000